 Home > Medical News > Latest Medical News > Notice on the public solicitation of comments on the "New Drug Benefits - Technical Guidelines for Risk Assessment"

Notice on the public solicitation of comments on the "New Drug Benefits - Technical Guidelines for Risk Assessment"

 Last Update: 2022-11-26
 Source: Internet
 Author: User

Tags

quality risk management

center veterinary medicine

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Notice on the public solicitation of comments on the "New Drug Benefits - Technical Guidelines for Risk Assessment"

Release date: 20221108

In order to further standardize and guide the benefit-risk assessment in the clinical development and evaluation of drugs, and provide technical specifications for reference, our center drafted the "New Drug Benefit-Risk Assessment Technical Guidelines", which has been discussed within the center and formed a draft
for comments.

We sincerely welcome all sectors of the community to put forward valuable comments and suggestions on the draft for comments, and feedback to us in time for subsequent improvement
.
The time limit for soliciting comments is 1 month
from the date of publication.

Your feedback should be sent to the email address of the following contact person:

Contact: Zhao Jianzhong, He Chunli

Contact: zhaojzh@cde.
org.
cn; hechl@cde.
org.
cn

Thank you for your participation and great support
.

Center for Drug Evaluation

November 8, 2022

Related attachments

serial number	Attachment name
1	"New Drug Benefits - Technical Guidelines for Risk Assessment". . pdf
2	The feedback form of "New Drug Benefits - Technical Guidelines for Risk Assessment" . docx
3	Drafting instructions for the "New Drug Benefits - Technical Guidelines for Risk Assessment" . pdf

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

united states logo(227)

ups united states(221)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.